The Cochrane Collaboration
Cochrane Reviews
Advanced search
Explore
New + Updated
Other languages
Full Text:
search & browse
|
by topic
|
full list of all reviews
|
by country of author
|
by date range
Audio summaries
|
Evidence Aid summaries
|
Cochrane Methodology abstracts
Home
Cochrane reviews
Search and browse free summaries
About Cochrane reviews
Example
Global impact
Most visited
The Cochrane Library
Full text
Press releases
User training
News
Newsroom
New reviews
Newsletters
Opportunities
Discussion lists
Events
Calendars
Colloquia
Workshops
Training resources
Training homepage
For Cochrane Library users
For authors & RGCs
For handsearchers & TSCs
About us
The organisation
Evidence-based health care
Support
Review Groups & Centres
Press & background docs
Getting involved
Administrative resources
Steering Group
Contact us
Home
Cochrane eviews
The Cochrane Library
News
Events
Training resources
For healthcare users
About us
Full text
Press releases
User training
The organization
Evidence-based healthcare
Support
Review Groups & Centres
Press & background docs
Get involved
Administrative Resources
Browse free summaries
About Cochrane Reviews
Introduction
Their impact
Review Groups
Get involved
Newsroom
New reviews
Newsletters
Opportunities
Discussion lists
Calendars
Colloquia
Workshops
Training homepage
For Cochrane Library users
For authors & RGCs
For handsearchers & TSCs
The Consumer Network
Consumer roles
Getting involved
by Topic (Review Group):
--Select topic (Review Group)--
Acute Respiratory Infections
Airways
Anaesthesia
Back
Behavioral Medicine Field
Bone, Joint and Muscle Trauma
Breast Cancer
Cancer Network
Child Health Field
Childhood Cancer
Colorectal Cancer
Complementary Medicine Field
Consumer Network
Consumers and Communication
Cystic Fibrosis and Genetic Disorders
Dementia and Cognitive Improvement
Depression, Anxiety and Neurosis
Developing Countries Network
Developmental, Psychosocial and Learning Problems
Drugs and Alcohol
Ear, Nose and Throat Disorders
Effective Practice and Organisation of Care
Epilepsy
Eyes and Vision
Fertility Regulation
Gynaecological Cancer
HIV/AIDS
Haematological Malignancies
Health Care of Older People Field
Health Equity Field
Health Promotion and Public Health Field
Heart
Hepato-Biliary
Hypertension
Incontinence
Infectious Diseases
Inflammatory Bowel Disease and Functional Bowel Disorders
Injuries
Lung Cancer
Menstrual Disorders and Subfertility
Metabolic and Endocrine Disorders
Methodology
Movement Disorders
Multiple Sclerosis
Musculoskeletal
Neonatal
Neurological Network
Neuromuscular Disease
Occupational Health Field
Oral Health
Pain, Palliative and Supportive Care
Peripheral Vascular Diseases
Pregnancy and Childbirth
Prehospital and Emergency Health Field
Primary Health Care Field
Prostatic Diseases and Urologic Cancers
Public Health
Rehabilitation and Related Therapies Field
Renal
Schizophrenia
Sexually Transmitted Diseases
Skin
Stroke
Tobacco Addiction
Upper Gastrointestinal and Pancreatic Diseases
Vaccines Field
Wounds
Browse by topic (Review Group)
-
For sub-topics (only reviews + protocols), click here
View stages (
what is this?
):
all
Titles
Protocols
Reviews
withdrawn
5HT-1 agonists for generalized anxiety
(protocol stage)
Acupuncture for chronic fatigue syndrome
(protocol stage)
Alprazolam for depression
(protocol stage)
withdrawn
Antidepressant dose-increase for non-responders to a standard dose for depression
(protocol stage)
withdrawn
Antidepressants alone versus psychotherapy alone for depression
(protocol stage)
withdrawn
Antidepressants for bipolar depression
(protocol stage)
New
Antidepressants for depression in physically ill people
(protocol stage)
Antipsychotic drugs for anorexia nervosa
(protocol stage)
Aripiprazole alone or in combination for acute mania
(protocol stage)
withdrawn
Benzodiazepines for generalized anxiety
(protocol stage)
withdrawn
Benzodiazepines for panic
(protocol stage)
Bibliotherapy for sexual dysfunction
(protocol stage)
withdrawn
Brief cognitive-behavioural therapies versus other brief psychological therapies for depression
(protocol stage)
withdrawn
Brief psychological therapies versus treatment as usual for depression
(protocol stage)
Bupropion for depression
(protocol stage)
withdrawn
Carbamazepine for bipolar affective disorders
(protocol stage)
withdrawn
Chlorpromazine for mania
(protocol stage)
Citalopram versus other anti-depressive agents for depression
(protocol stage)
withdrawn
Cognitive behavioural therapy for bipolar disorder
(protocol stage)
Cognitive behavioural therapy for insomnia
(protocol stage)
Collaborative care for depression and anxiety problems in primary care
(protocol stage)
withdrawn
Combinations of pharmacotherapy and psychotherapy for depression
(protocol stage)
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
(protocol stage)
Combined psychotherapy plus benzodiazepines for panic disorder
(protocol stage)
withdrawn
Computer assisted self-help materials for the treatment of depression
(protocol stage)
Consultation letters for medically unexplained physical symptoms
(protocol stage)
Continuation and maintenance treatments for depressive disorder in older adults
(protocol stage)
Debriefing for the prevention of psychological trauma in women following childbirth
(protocol stage)
Duloxetine versus other anti-depressive agents for depression
(protocol stage)
withdrawn
Duration of treatment with antidepressants in depressive disorder
(protocol stage)
withdrawn
ECT for depression
(protocol stage)
Escitalopram versus other types of pharmacotherapy for depression
(protocol stage)
Exercise for older depressed people
(protocol stage)
Family therapy for anorexia nervosa
(protocol stage)
Fluvoxamine versus other anti-depressive agents for depression
(protocol stage)
withdrawn
Gabapentin in the treatment of acute affective episodes in bipolar disorder:efficacy and acceptability
(protocol stage)
Hydroxyzine for generalised anxiety disorder
(protocol stage)
withdrawn
Initial high dose versus standard dose of antidepressants for depression
(protocol stage)
Interventions for helping people recognise early signs of recurrence in depression
(protocol stage)
Interventions for mood and anxiety disorders, and self harm in young offenders
(protocol stage)
New
Interventions for preventing relapse and recurrence after the first episode of a depressive disorder in young people
(protocol stage)
withdrawn
Interventions to reduce benzodiazepine prescribing
(protocol stage)
withdrawn
Lamotrigine in the maintenance treatment of bipolar disorder: efficacy and acceptability
(protocol stage)
withdrawn
Lamotrigine in the treatment of acute affective episodes in bipolar disorder : efficacy and acceptability
(protocol stage)
Light therapy for seasonal affective disorder
(protocol stage)
withdrawn
Lithium for acute mania
(protocol stage)
withdrawn
Lithium for bipolar depression
(protocol stage)
withdrawn
Long-term treatments for older depressed people
(protocol stage)
Media-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adults
(protocol stage)
Milnacipran versus other anti-depressive agents for depression
(protocol stage)
withdrawn
Minimal contact psychotherapy for depression
(protocol stage)
Mirtazapine versus other anti-depressive agents for depression
(protocol stage)
Multiple session early psychological intervention to prevent and treat post-traumatic stress disorder
(protocol stage)
Neurosurgery for obsessive-compulsive disorder, other anxiety disorders and depressive disorders
(protocol stage)
Newer anticonvulsants in the treatment of anxiety disorders
(protocol stage)
Olanzapine in long-term treatment for bipolar disorder
(protocol stage)
Omega 3 fatty acids for depression
(protocol stage)
Oxcarbazepine in the treatment of acute affective episodes in bipolar disorder: efficacy and acceptability
(protocol stage)
Paroxetine versus other anti-depressive agents for depression
(protocol stage)
Pharmacological treatments for chronic fatigue syndrome in adults
(protocol stage)
withdrawn
Pharmacological versus non-pharmacological interventions for refractory depression
(protocol stage)
Pharmacotherapy and psychotherapy for body dysmorphic disorder
(protocol stage)
New
Pharmacotherapy for anxiety disorders and comorbid alcohol dependency
(protocol stage)
Pharmacotherapy for anxiety disorders in children and adolescents
(protocol stage)
Pharmacotherapy for prevention of post-traumatic stress disorder
(protocol stage)
withdrawn
Pindolol for augmenting antidepressant treatment
(protocol stage)
Prevention of suicide and suicidal behaviour in adolescents
(protocol stage)
Problem solving treatment (PST) for emotional problems in primary care
(protocol stage)
Psychological therapies for medically unexplained symptoms in children and adolescents
(protocol stage)
Psychological therapies for the prevention and treatment of post-traumatic stress disorder in children and adolescents
(protocol stage)
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder
(protocol stage)
Psychotherapy for depression in children and adolescents
(protocol stage)
withdrawn
Quetiapine alone or in combination for acute mania
(protocol stage)
Reiki treatment for psychological symptoms
(protocol stage)
Return to work interventions for adjustment disorders
(protocol stage)
withdrawn
Serotonin reuptake inhibitors and new generation antidepressants for panic disorder
(protocol stage)
Sertraline versus other anti-depressive agents for depression
(protocol stage)
Sports, games and play-based interventions for post-traumatic stress disorder (PTSD)
(protocol stage)
withdrawn
Surgery for obsessive compulsive disorder
(protocol stage)
Tai Chi for depression
(protocol stage)
withdrawn
The efficacy of optimum nortriptyline blood levels for treating depression
(protocol stage)
withdrawn
Thioridazine for anxiety and depressive disorders
(protocol stage)
Traditional Chinese medicinal herbs for the treatment of idiopathic chronic fatigue and chronic fatigue syndrome
(protocol stage)
Transcranial magnetic stimulation for post-traumatic stress disorder
(protocol stage)
Venlafaxine versus other anti-depressive agents for depression
(protocol stage)
Ziprasidone alone or in combination for acute mania
(protocol stage)
top of page
|
contact us
|
about this site
|
disclaimer
|
privacy